Skip to main content
. 2022 Feb 14;29(1):534–547. doi: 10.1080/10717544.2022.2036872

Figure 4.

Figure 4.

MAP skin permeation and skin retention from MAP solution, MAP ethosomes (FE7), MAP ethosomal (FE7) gel, MAP niosomes (FN3) and MAP niosomal (FN3) gel.